The raised guidance (+3.6% at midpoint for sales, +3.6% for adjusted EPS) and 18% backlog growth signal accelerating end-market demand. With 63% analyst bullish rating and strong first-half momentum, look for continued operational leverage in H2 if tariff/trade headwinds remain contained. The pension settlement charge ($24M non-cash) is a one-time item — monitor Q3 margin trajectory for any reinvestment drag.
Price Chart
Executive Summary
Nordson reported a record second quarter with sales up 8% YoY to $741M and adjusted EPS up 18% to $2.86, exceeding the $2.85 consensus. The company raised full-year guidance for sales ($2,930-$3,010M) and adjusted EPS ($11.30-$11.80), citing broad-based growth across all segments and strong backlog (+18% YoY).
Key Financial Metrics
Key Facts
- Q2 fiscal 2026 sales were a record $741M, up 8% YoY (7% organic, 3% FX tailwind, -0.8% from medical divestiture)
- Adjusted EPS was a record $2.86, up 18% YoY from $2.42; GAAP EPS was $2.09, including a $0.43 non-cash pension settlement charge and $0.18 non-cash loss on minority investments
- Backlog up 18% YoY entering Q3, with broad-based order momentum
- Full-year fiscal 2026 guidance raised: sales now $2,930-$3,010M (prev. $2,830-$2,950M) and adjusted EPS $11.30-$11.80 (prev. $10.80-$11.50)
- All three segments posted record or best-ever Q2 sales: Industrial Precision Solutions +10%, Medical & Fluid Solutions +5%, Advanced Technology Solutions +10%
- Completed acquisition of CapstanAG Systems (precision agriculture) on March 16, 2026 — small bolt-on
- Free cash flow conversion was 119% in Q2 (excl. pension charge and minority investment non-cash items)
Financial Impact
Raised full-year adjusted EPS guidance by ~$0.40 at midpoint ($11.55 vs. $11.15) on higher revenue outlook; Q2 adjusted EPS beat by $0.01 vs. consensus of $2.85; record sales and EBITDA margins
Risk Factors
- Tariff/trade policy uncertainty and currency volatility could pressure organic growth and margins
- Downside risk to Q3 guidance ($2.95-$3.15) if end-market demand softens or FX turns negative
- Debt paydown remains slow ($107M repaid in H1 vs $224M in FY2025); leverage still elevated at ~2.3x EBITDA
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000072331-26-000022 |
| Document: ndsn-20260520.htm | 0000072331-26-000022 |
| Document: 0000072331-26-000022-index-headers.html | 0000072331-26-000022 |
| Document: 0000072331-26-000022-index.html | 0000072331-26-000022 |
| Document: 0000072331-26-000022.txt | 0000072331-26-000022 |
| 8-K Data (Synthetic) | 0000072331-26-000022 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 29d ago | Insider Cluster | $317.49 $314.47 | ▼ −0.95% | ▲ +0.20% | $332.89 (+4.85%) |
Aug 28, 2026 5w ago | Insider Cluster | $324.06 $318.36 | ▼ −1.76% | ▼ −1.87% | $332.89 (+2.72%) |
Aug 28, 2026 5w ago | Insider Cluster | $324.59 $318.36 | ▼ −1.92% | ▼ −2.03% | $332.89 (+2.56%) |
Jul 23, 2026 10w ago | Institutional Cluster | $292.10 $295.23 | ▲ +1.07% | ▲ +0.60% | $332.89 (+13.96%) |
Jun 3, 2026 17w ago | 8-K | $289.04 $278.57 | ▼ −3.62% | ▲ +0.20% | $332.89 (+15.17%) |
May 20, 2026 19w ago | 8-K | $285.43 $287.10 | ▲ +0.59% | ▼ −1.26% | $332.89 (+16.63%) |
Apr 15, 2026 24w ago | Insider Cluster | $273.87 $279.45 | ▲ +2.04% | ▲ +0.40% | $332.89 (+21.55%) |
Apr 8, 2026 25w ago | Insider Cluster | $274.37 $275.00 | ▲ +0.23% | ▼ −3.29% | $332.89 (+21.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access